INTANGIBLE ASSETS IN INDIAN PHARMACEUTICALS: DISCLOSURE PRACTICES AND IMPACT ON VALUE CREATION - Image 1

£72.99

It has never been this cheap. We have no record of a lower price.

£73 today · cheaper than every other day in the last 1 months

LAP Lambert Academic Publishing INTANGIBLE ASSETS IN INDIAN PHARMACEUTICALS: DISCLOSURE PRACTICES AND IMPACT ON VALUE CREATION

Name: INTANGIBLE ASSETS IN INDIAN PHARMACEUTICALS: DISCLOSURE PRACTICES AND IMPACT ON VALUE CREATION
Brand: LAP Lambert Academic Publishing
Price: 72.99 GBP
Availability: InStock

Subjects

Price data last checked 30 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 13 days · 13 data points (no recent data)

Historical

Generating forecast…

View at Amazon ↗

Subjects

Price data last checked 30 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey

↑ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 13 days • 1 price levels

Days at Price

Price Analysis

Most common price: £73 (13 days, 100.0%)

Price range: £73 - £73

Price levels: 1 different prices over 13 days

Description

This study analyzed intangible asset (IA) disclosure, trends, and value creation impact in ten Nifty Pharma companies (2015-21). Piramal Enterprises Ltd. led in both mandatory and voluntary disclosures. While most companies showed increasing IA values, their impact on value creation varied. Aurobindo Pharma and Glenmark showed significant IA impact on ROE, ROIC, Tobin's Q, and PB ratio, while Cadila, Divi's, and Dr. Reddy's saw impact on EVA. However, IA had no significant impact on firm value for Biocon, Cipla, Lupin, Piramal, and Sun Pharma in these specific metrics. Overall, IA significantly impacted profitability (ROA, ROE, ROIC, PAT) and firm value (Tobin's Q). Suggestions include improving disclosure for Cadila and Sun Pharma, boosting IA values for Divi's and Lupin, and continuing IA prioritization for Aurobindo and Glenmark to maximize stakeholder value.

Product Specifications

Brand: LAP Lambert Academic Publishing
Format: paperback
ASIN: 6208447887
Category: Books > Subjects
Domain: Amazon UK
Release Date: 16 June 2025
Listed Since: 15 July 2025

Barcode

No barcode data available

It has never been this cheap. We have no record of a lower price.

LAP Lambert Academic Publishing INTANGIBLE ASSETS IN INDIAN PHARMACEUTICALS: DISCLOSURE PRACTICES AND IMPACT ON VALUE CREATION

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Financial Performance of MNCs in Indian Pharmaceutical Industry: A Study during the Post-liberalisation Era

Financial Performance Analysis of Pharmaceutical Enterprises in India: Financial Performance Analysis

TRIPs and Indian Pharmaceautical Industry

Accounting For Intangible Assets: Research and Development Cost of Select Units

Farmakologicheskaya korrektsiya: i kontrol' techeniya giperlipoproteinemiy i ishemicheskoy bolezni serdtsa

TRIPS Agreement and Indian Pharmaceutical Industry: Emerging Firm Strategies and Economic Aspects of Affordability and Accessibility to Drugs

Capital Market Efficiency: Testing the Efficiency of Indian Capital Market with Respect to Pharmaceutical Industry

Analytical Method Development and Validation: Development and Validation of Analytical Methods for Active Pharmaceutical Ingredients in Pharmaceutical Dosage Form

IMPACT OF INVESTOR BIASES ON INVESTMENT DECISIONS OF INVESTORS: EVIDENCE FROM PAKISTAN

Analysis of Financial Performance of Software companies in India

Financial Performance of Pharmaceutical Industry: In India

Financial Performance and Corporate Strategy of Indian Business Groups: A Study and Synthesis

Impact of Mergers and Acquisitions on Indian Pharmaceutical Industry: Productivity Growth, Technical Efficiency and Stochastic Production Function during Pre and Post-Merger Periods

A Study of the Indian Pharmaceutical Industry in the New Patent Regime: Untangling Sources of Competitive Advantage in Unpredictable Environments

Development of Analytical Methods for Pharmaceutical Formulations

CLINICAL PHARMACY PRACTICE

The Indian Pharmaceutical Landscape: History, Current Standings, and, Future beyond 2025

ASSESSING INDIAN INDUSTRIES ON THE BASIS OF FINANCIAL RATIOS: USING DATA MINING TECHNIQUES

Total Quality Management Practices In Indian Pharmaceutical Industry: A Study on Selected Companies

Investor's Behavior In Indian Capital Market

R&D COLLABORATIONS TOWARD INNOVATION IN BIOTECHNOLOGY AND BIOMEDICINE: POLICY IMPLICATIONS

Corporate Finance and business valuation

A Guide to Pharmacist for Responding Symptoms of Minor Ailments: A Reference Guide to Community Pharmacist

Corporate Interim Financial Reporting: Timeliness and Extent of Disclosure

It has never been this cheap. We have no record of a lower price.

LAP Lambert Academic Publishing INTANGIBLE ASSETS IN INDIAN PHARMACEUTICALS: DISCLOSURE PRACTICES AND IMPACT ON VALUE CREATION

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Financial Performance of MNCs in Indian Pharmaceutical Industry: A Study during the Post-liberalisation Era

Financial Performance Analysis of Pharmaceutical Enterprises in India: Financial Performance Analysis

TRIPs and Indian Pharmaceautical Industry

Accounting For Intangible Assets: Research and Development Cost of Select Units

Farmakologicheskaya korrektsiya: i kontrol' techeniya giperlipoproteinemiy i ishemicheskoy bolezni serdtsa

TRIPS Agreement and Indian Pharmaceutical Industry: Emerging Firm Strategies and Economic Aspects of Affordability and Accessibility to Drugs

Capital Market Efficiency: Testing the Efficiency of Indian Capital Market with Respect to Pharmaceutical Industry

Analytical Method Development and Validation: Development and Validation of Analytical Methods for Active Pharmaceutical Ingredients in Pharmaceutical Dosage Form

IMPACT OF INVESTOR BIASES ON INVESTMENT DECISIONS OF INVESTORS: EVIDENCE FROM PAKISTAN

Analysis of Financial Performance of Software companies in India

Financial Performance of Pharmaceutical Industry: In India

Financial Performance and Corporate Strategy of Indian Business Groups: A Study and Synthesis

Impact of Mergers and Acquisitions on Indian Pharmaceutical Industry: Productivity Growth, Technical Efficiency and Stochastic Production Function during Pre and Post-Merger Periods

A Study of the Indian Pharmaceutical Industry in the New Patent Regime: Untangling Sources of Competitive Advantage in Unpredictable Environments

Development of Analytical Methods for Pharmaceutical Formulations

CLINICAL PHARMACY PRACTICE

The Indian Pharmaceutical Landscape: History, Current Standings, and, Future beyond 2025

ASSESSING INDIAN INDUSTRIES ON THE BASIS OF FINANCIAL RATIOS: USING DATA MINING TECHNIQUES

Total Quality Management Practices In Indian Pharmaceutical Industry: A Study on Selected Companies

Investor's Behavior In Indian Capital Market

R&D COLLABORATIONS TOWARD INNOVATION IN BIOTECHNOLOGY AND BIOMEDICINE: POLICY IMPLICATIONS

Corporate Finance and business valuation

A Guide to Pharmacist for Responding Symptoms of Minor Ailments: A Reference Guide to Community Pharmacist

Corporate Interim Financial Reporting: Timeliness and Extent of Disclosure